financetom
Business
financetom
/
Business
/
Bunge receives China regulatory approval for Viterra deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bunge receives China regulatory approval for Viterra deal
Jun 13, 2025 11:15 AM

CHICAGO, June 13 (Reuters) - Global agribusiness Bunge

Global SA ( BG ) has received regulatory approval from China for

its acquisition of grain handler Viterra and expects to close

the $34 billion deal "on or around July 2," the company said in

a statement on Friday.

The deal, first announced in 2023, will create a global crop

trading and processing giant closer in scale to chief rivals

Archer-Daniels-Midland ( ADM ) and Cargill.

Approval from China was the final regulatory approval

Bunge needed to finalize the deal after gaining approvals from

regulators in

Canada

, the

European Union

and other markets.

"Achieving this regulatory milestone is a significant

step forward and clears the way for closing of the transaction.

This approval underscores the strategic rationale behind

bringing Bunge and Viterra together to create a premier global

agribusiness company," CEO Greg Heckman said in an emailed

statement.

Bunge shares were up 6.1% at midday on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bird Construction Selected for Five Projects Exceeding $575 Million
Bird Construction Selected for Five Projects Exceeding $575 Million
Aug 12, 2024
09:19 AM EDT, 08/12/2024 (MT Newswires) -- Bird Construction ( BIRDF ) , whose shares jumped 3.7% on Friday, said on Monday that it has been selected for five projects with a combined value of more than $575 million. These include multi-year mine infrastructure work in Eastern Canada and three long-term care projects and a multi-building institutional project in Western...
Taoping Says July Total Contract Revenue Value Rises 30%
Taoping Says July Total Contract Revenue Value Rises 30%
Aug 12, 2024
09:15 AM EDT, 08/12/2024 (MT Newswires) -- Taoping ( TAOP ) said Monday that its total contract revenue value rose 30% in July from a year earlier to about 27.4 million Chinese renminbi ($3.8 million). The technology company attributed the increase to strong demand for its artificial intelligence-based products. Taoping ( TAOP ) shares were nearly 9% higher in premarket...
Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review
Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review
Aug 12, 2024
Friday, the FDA announced it would require additional time to complete its review of Humacyte Inc.’s Biologic License Application (BLA) for the acellular tissue-engineered vessel (ATEV) in the vascular trauma indication. The ATEV trauma program BLA was submitted to the FDA in December 2023, and the FDA granted a Priority Review in February 2024 and assigned a PDUFA date of...
Starbucks, Elliott in talks over on a settlement, CNBC reports
Starbucks, Elliott in talks over on a settlement, CNBC reports
Aug 12, 2024
Aug 12 (Reuters) - Starbucks ( SBUX ) and activist investor Elliott Management are talking about a settlement, CNBC reported on Monday, citing sources. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved